Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Jeena Sikho Lifecare Ltd (JSLL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544476 NSE: JSLL Trading | Small Cap | Jeena Sikho Lifecare Share Price
₹508.55 -1.10 (-0.22%)
As on 21-Sep'26 16:59
Jeena Sikho Lifecare Ltd (JSLL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544476 NSE: JSLL Trading | Small Cap | Jeena Sikho Lifecare Share Price
₹508.55 -1.10 (-0.22%)
As on 21-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹6,321 Cr.
Current Price
₹508.6
52-Week Low / High
₹486 / 850
TTM EPS
₹19
TTM Sales
₹851 Cr.
Book Value per Share
₹42.7
P/E Ratio
26.73
Lower than its 5-year historical median
Industry PE
39.7
Price to Book (P/B)
11.92
Lower than its 5-year historical median
Price to Sales (P/S)
7.42
Lower than its 5-year historical median
EV/EBITDA
16.16
Lower than its 5-year historical median
Dividend Yield
0.88%
Profitability Efficiency
Return on Equity (ROE)
61.61%
Outperforms industry median
Return on Capital Employed (ROCE)
84.75%
Outperforms industry median
Return on Assets (ROA)
41.17%
Operating Profit Margin
43.8%
Net Profit Margin
27.67%
Gross Profit Margin
43.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
70.84%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
149.27%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
177.33%
Asset Quality
Promoter Holding
63.62%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹505 Cr.
Equity
₹24.9 Cr.
Face Value
₹2
All Time Low / High
₹485.60 / 850.00
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Weak
Is Jeena Sikho Lifecare Ltd a good quality company?
Jeena Sikho Lifecare Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Jeena Sikho Lifecare Ltd performance compare with that of its Peers?
Revenue growth of Jeena Sikho Lifecare Ltd vs industry peers?
Jeena Sikho Lifecare Ltd revenue CAGR is 76.18%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Jeena Sikho Lifecare Ltd?
Promoters hold 63.62% of the Jeena Sikho Lifecare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Jeena Sikho Lifecare Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -21.01% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jeena Sikho Lifecare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 40.1% | 37.6% | 50% | 40.9% | 53.3% | 59.1% | 51.4% | 84.8% | - |
| Value Creation Index ⓘ | NA | NA | 2.0 | 1.8 | 2.7 | 1.9 | 2.8 | 3.2 | 2.7 | 5.3 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 106 | 94.4 | 136 | 146 | 204 | 324 | 469 | 801 | 851 |
| Sales YoY Gr. | - | NA | NA | -10.8% | 43.8% | 7.8% | 39.2% | 59.1% | 44.6% | 70.8% | - |
| Adj EPS ⓘ | 0 | 0 | 0.7 | 0.7 | 1.1 | 1.2 | 2.7 | 5.5 | 6.2 | 17.9 | 19 |
| YoY Gr. | - | NA | NA | -4.1% | 62.9% | 3.5% | 127.1% | 104.1% | 14.1% | 186.5% | - |
| BVPS (₹) ⓘ | 0 | 0 | 1 | 1.7 | 2.9 | 4 | 10.1 | 15.5 | 20.6 | 37.4 | 42.7 |
| Adj Net Profit ⓘ | 0 | 0 | 6 | 5.7 | 10.4 | 10.7 | 33.4 | 67.9 | 77.6 | 222 | 237 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 1.3 | 11.7 | 17.5 | 17.5 | 17.2 | 36.7 | 84.5 | 262 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 12 | 1.1 | 0.7 | 0.4 | 0.1 | 0 | 0.1 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 42.6% | 57.8% | 70.8% | ||||
| Adj EPS ⓘ | NA | 73.4% | 88.3% | 186.5% | ||||
| BVPSⓘ | NA | 67% | 54.6% | 81.9% | ||||
| Share Price | - | - | -21.5% | -37.8% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 75 | 52.7 | 55.1 | 35.4 | 41.1 | 42.7 | 34.6 | 61.4 | 47.6 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 10 | 11.2 | 12.6 | 12.4 | 22.7 | 28.7 | 30 | 43.8 | 42.6 |
| Net Profit Mgn % ⓘ | 0 | 0 | 5.7 | 6.1 | 7.7 | 7.3 | 16.4 | 20.9 | 16.5 | 27.7 | 27.8 |
| Debt to Equity ⓘ | 0 | 0 | 2 | 0.9 | 0.5 | 0.2 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 82 | 50 | 54 | 70 | 77 | 79 | 62 | 64 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 26 | 21 | 20 | 20 | 30 | 42 | 24 | 40 |
Valuation of Jeena Sikho Lifecare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'22 | Mar'23 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Sales | 147 | 205 | 469 | 801 |
| Operating Expenses ⓘ + | 128 | 159 | 328 | 451 |
| Operating Profit ⓘ | 18 | 46 | 141 | 350 |
| Operating Profit Margin (%) | 12.3% | 22.4% | 30.0% | 43.7% |
| Other Income ⓘ + | 1 | 3 | 7 | 8 |
| Interest ⓘ | 1 | 1 | 11 | 14 |
| Depreciation ⓘ | 3 | 3 | 29 | 48 |
| Profit Before Tax ⓘ | 15 | 44 | 108 | 297 |
| Tax ⓘ | 4 | 11 | 28 | 76 |
| Profit After Tax | 11 | 34 | 80 | 222 |
| PAT Margin (%) | 7.6% | 16.4% | 17.0% | 27.7% |
| Adjusted EPS (₹) | 1.2 | 2.7 | 6.4 | 17.9 |
| Dividend Payout Ratio (%) | 0% | 8.20% | 17% | 25.20% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 37 | 126 | 255 | 464 | |||||||
| Debt + | 7 | 1 | 10 | 0 | |||||||
| Minority Interest | -0 | 0 | 0 | -0 | |||||||
| Trade Payables | 5 | 6 | 16 | 23 | |||||||
| Others Liabilities ⓘ | 13 | 18 | 131 | 176 | |||||||
| Total Liabilities ⓘ | 62 | 151 | 413 | 664 | |||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 29 | 60 | 253 | 293 | |||||||
| CWIP ⓘ | 5 | 1 | 13 | 3 | |||||||
| Investments ⓘ | 0 | 5 | 4 | 110 | |||||||
| Inventories | 6 | 4 | 12 | 20 | |||||||
| Trade Receivables | 9 | 22 | 85 | 70 | |||||||
| Cash Equivalents | 3 | 32 | 23 | 109 | |||||||
| Others Assets ⓘ | 10 | 27 | 24 | 59 | |||||||
| Total Assets ⓘ | 62 | 151 | 413 | 664 | |||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 16 | 15 | 85 | 254 |
| Cash Flow From Investing Activity ⓘ + | -18 | -33 | -64 | -202 |
| Cash Flow From Financing Activity ⓘ + | -5 | 48 | -22 | -59 |
| Net Cash Flow ⓘ | -7 | 29 | -2 | -7 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 30.66 | 41.31 | 41.94 | 61.61 | ||||||
| ROCE (%) | 37.03 | 53.05 | 60.06 | 84.75 | ||||||
| Asset Turnover Ratio | 2.38 | 1.93 | 1.66 | 1.49 | ||||||
| PAT to CFO Conversion(x) | 1.45 | 0.44 | 1.06 | 1.14 | ||||||
| Working Capital Days | ||||||||||
| Receivable Days | 22.50 | 27.70 | 41.60 | 35.30 | ||||||
| Inventory Days | 15.80 | 9.30 | 6.10 | 7.20 | ||||||
| Payable Days | 112 | 112.50 | 73.40 | 77.60 | ||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Jeena Sikho Lifecare Ltd FAQs
The current trading price of Jeena Sikho Lifecare on 21-Sep-2026 16:59 is ₹508.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Sep-2026 the market cap of Jeena Sikho Lifecare stood at ₹6,321.3 Cr
The latest P/E ratio of Jeena Sikho Lifecare as of 20-Sep-2026 is 26.72.
The latest P/B ratio of Jeena Sikho Lifecare as of 20-Sep-2026 is 11.92.
The 52-week high of Jeena Sikho Lifecare is ₹850.0 and the 52-week low is ₹485.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jeena Sikho Lifecare is ₹851 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Jeena Sikho Lifecare Ltd is a average quality company.
The key valuation ratios of Jeena Sikho Lifecare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Jeena Sikho Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is ayurvedic healthcare company headquartered in Zirakpur, Punjab. Founded by Manish Grover (popularly known as Acharya Manish) in the year 2017, the main motive of the company is to build a healthy India through preventive measures by providing authentic and good quality ayurvedic products.
Ayurveda is an alternative medical system with historical roots in Indian subcontinent. The origin of Ayurveda dates back to the Vedic era. It was developed more than 3,000 years ago in India. It is based on the belief that health and wellness depend on a delicate balance between the mind, body, and spirit. Its main goal is to promote good health, not fight disease. Ayurvedic theory states that all areas of life impact one's health, so it follows that the Vedas cover a wide variety of topics, including health and healthcare techniques, astrology, spirituality, government and politics, art, and human behavior.
Business area of the company
The company is a developing health care services providers in India. The company has portfolio of over a wide range of Ayurvedic products. The company also conducts various health checkup camps, yoga sessions to make people aware of their health problem.
Key events and milestones
- 2017: Incorporation of the company.
- 2018: Company came up with project i.e. Shuddhi Ayurveda.
- 2020: Company opened the first ayurvedic Panchkarma hospital in India.
- 2021: Company converted into Public Limited Company.
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
